ICV-administered BMN 250 (NAGLU-IGF2) is well tolerated and reduces heparan sulfate accumulation in the CNS of subjects with Sanfilippo syndrome type B (MPS IIIB)
2018; Elsevier BV; Volume: 123; Issue: 2 Linguagem: Inglês
10.1016/j.ymgme.2017.12.270
ISSN1096-7206
AutoresNicole Muschol, Maureen Cleary, María L. Couce, Adam J. Shaywitz, Heather Cahan, Anita Grover, Stephen M. Maricich, Andrew C. Melton, Lynn Smith, María José de Castro López,
Tópico(s)Hereditary Neurological Disorders
Referência(s)